Next-generation treatments: Immunotherapy and advanced therapies for COVID-19
Jenny Andrea Arévalo-Romero,
No information about this author
Sandra M. Chingaté-López,
No information about this author
Bernardo Camacho
No information about this author
et al.
Heliyon,
Journal Year:
2024,
Volume and Issue:
10(5), P. e26423 - e26423
Published: Feb. 19, 2024
The
COVID-19
pandemic,
caused
by
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2),
emerged
in
2019
following
prior
outbreaks
of
coronaviruses
like
SARS
and
MERS
recent
decades,
underscoring
their
high
potential
infectivity
humans.
Insights
from
previous
have
played
a
significant
role
developing
effective
strategies
to
mitigate
the
global
impact
SARS-CoV-2.
As
January
7,
2024,
there
been
774,075,242
confirmed
cases
worldwide.
To
date,
13.59
billion
vaccine
doses
administered,
7,012,986
documented
fatalities
(https://www.who.int/)Despite
progress
addressing
rapid
evolution
SARS-CoV-2
challenges
human
defenses,
presenting
ongoing
challenges.
emergence
new
lineages,
shaped
mutation
recombination
processes,
has
led
successive
waves
infections.
This
scenario
reveals
need
for
next-generation
vaccines
as
crucial
requirement
ensuring
protection
against
demand
calls
formulations
that
trigger
robust
adaptive
immune
response
without
leading
inflammation
linked
with
infection.Key
mutations
detected
Spike
protein,
critical
target
neutralizing
antibodies
design
—specifically
within
Receptor
Binding
Domain
region
Omicron
variant
lineages
(B.1.1.529),
currently
dominant
worldwide,
intensified
concerns
due
association
immunity
evasion
vaccinations
infections.As
world
deals
this
evolving
threat,
narrative
extends
realm
emerging
variants,
each
displaying
implications
remain
largely
misunderstood.
Notably,
JN.1
lineage
is
gaining
prevalence,
early
findings
suggest
it
stands
among
immune-evading
characteristic
attributed
its
L455S.
Moreover,
detrimental
consequences
novel
bear
particularly
on
immunocompromised
individuals
older
adults.
Immunocompromised
face
such
suboptimal
responses
vaccines,
rendering
them
more
susceptible
disease.
Similarly,
adults
an
increased
risk
disease
presence
comorbid
conditions,
find
themselves
at
heightened
vulnerability
develop
Thus,
recognizing
these
intricate
factors
effectively
tailoring
public
health
protect
vulnerable
populations.
In
context,
review
aims
describe,
analyze,
discuss
current
treatments
encompassing
immunotherapeutic
approaches
advanced
therapies
complements
will
offer
solutions
counter
disadvantages
existing
options.
Preliminary
outcomes
show
virus
address
immunomodulatory
associated
COVID-19.
Furthermore,
capacity
promote
tissue
repair
demonstrated,
which
can
be
noteworthy
who
stand
actors
landscape
possess
broader
potential,
offering
wide
range
variants
enhancing
ability
constant
virus.
are
projected
treatment
alternatives
managing
Chronic
Post-COVID-19
syndromeand
long-term
complications.
Language: Английский
Characterization of SARS-CoV-2 Variants in Military and Civilian Personnel of an Air Force Airport during Three Pandemic Waves in Italy
Microorganisms,
Journal Year:
2023,
Volume and Issue:
11(11), P. 2711 - 2711
Published: Nov. 5, 2023
We
investigated
SARS-CoV-2
variants
circulating,
from
November
2020
to
March
2022,
among
military
and
civilian
personnel
at
an
Air
Force
airport
in
Italy
order
classify
viral
isolates
a
potential
hotspot
for
virus
spread.
Positive
samples
were
subjected
Next-Generation
Sequencing
(NGS)
of
the
whole
genome
Sanger
sequencing
spike
coding
region.
Phylogenetic
analysis
classified
traced
their
evolutionary
relationships.
Clusters
identified
using
70%
cut-off.
methods
yielded
comparable
results
terms
variant
classification.
In
2021,
we
several
variants,
including
B.1.258
(4/67),
B.1.177
(9/67),
Alpha
(B.1.1.7,
9/67),
Gamma
(P.1.1,
4/67),
Delta
(4/67).
only
Omicron
its
sub-lineage
observed
(37/67).
screened
detect
naturally
occurring
resistance
genomic
regions,
target
new
therapies,
comparing
them
Wuhan
Hu-1
reference
strain.
Interestingly,
2/30
non-Omicron
carried
G15S
3CLpro
substitution
responsible
reduced
susceptibility
protease
inhibitors.
On
other
hand,
unusual
substitutions
A1803V,
D1809N,
A949T
on
PLpro,
D216N
3CLpro.
Finally,
P323L
RdRp
regions
was
not
associated
with
mutational
pattern
related
polymerase
inhibitor
resistance.
This
study
highlights
importance
continuous
surveillance
monitor
evolution
general
population,
as
well
restricted
communities.
Language: Английский
Analyzing the emerging patterns of SARS‐CoV‐2 Omicron subvariants for the development of next‐gen vaccine: An observational study
Health Science Reports,
Journal Year:
2023,
Volume and Issue:
6(10)
Published: Oct. 1, 2023
Understanding
the
prevalence
and
impact
of
SARS-CoV-2
variants
has
assumed
paramount
importance.
This
study
statistically
analyzed
to
effectively
track
emergence
spread
highlights
importance
such
investigations
in
developing
potential
next-gen
vaccine
combat
continuously
emerging
Omicron
subvariants.
Language: Английский
WHO-classified COVID-19 ‘variant of interest’ JN.1: A community health concern in the winter and festive season
Clinical Infection in Practice,
Journal Year:
2024,
Volume and Issue:
21, P. 100348 - 100348
Published: Jan. 1, 2024
Language: Английский
Global domination of the recently VoI-classified 'JN.1′ outcompeting other variants – Comparing the vaccines’ efficacy
Clinical Infection in Practice,
Journal Year:
2024,
Volume and Issue:
22, P. 100358 - 100358
Published: April 1, 2024
Language: Английский
Immunization against Medically Important Human Coronaviruses of Public Health Concern
Nabil Awni Nimer,
No information about this author
Seema N Nimer
No information about this author
Canadian Journal of Infectious Diseases and Medical Microbiology,
Journal Year:
2024,
Volume and Issue:
2024(1)
Published: Jan. 1, 2024
SARS‐CoV‐2
is
a
virus
that
affects
the
human
immune
system.
It
was
observed
to
be
on
rise
since
beginning
of
2020
and
turned
into
life‐threatening
pandemic.
Scientists
have
tried
develop
possible
preventive
therapeutic
drug
against
severe
acute
respiratory
syndrome
coronavirus‐2
(SARS‐CoV‐2)
other
related
coronaviruses
by
assessing
COVID‐19‐recovered
persons’
immunity.
This
study
aims
review
immunization
SARS‐CoV‐2,
along
with
exploring
interventions
been
developed
for
prevention
SARS‐CoV‐2.
also
highlighted
role
phototherapy
in
treating
SARS‐CoV
infection.
The
adopted
approach
gathering
information
available
progress
has
made
treatment
COVID‐19.
Various
vaccinations,
including
nucleotide,
subunit,
vector‐based
vaccines,
as
well
attenuated
inactivated
forms
already
shown
prophylactic
efficacy
Middle
East
coronavirus
(MERS‐CoV)
SARS‐CoV,
summarized.
Neutralizing
non‐neutralizing
antibodies
are
all
associated
viral
infections.
Because
there
no
specific
antiviral
vaccine
or
therapies
coronaviruses,
main
strategy
supportive
care,
which
reinforced
combining
broad‐spectrum
antivirals,
convalescent
plasma,
corticosteroids.
COVID‐19
challenge
keep
reconsidering
usual
approaches
regulatory
evaluation
result
getting
mixed
complicated
findings
licensing
procedures.
However,
it
medicinal
herbs
play
an
important
infection
upper
tract,
principal
symptom
due
their
natural
bioactive
composite.
some
Traditional
Chinese
Medicines
contain
mutagens
nephrotoxins
toxicological
properties
majority
herbal
remedies
unknown.
Therefore,
treat
conventional
treatment,
recommended
herb‐drug
interaction
examined
thoroughly.
Language: Английский
The flow of humanitarian aids is the urgency to address food security and health safety in the Gaza Strip: an open call
International Journal of Surgery Global Health,
Journal Year:
2024,
Volume and Issue:
7(6)
Published: Oct. 17, 2024
Dear
Editor,
Table
1
-
Reported
communicable
diseases
in
the
Gaza
Strip
population
since
October
2023.
Disease
Cases
Skin
rash
12
635
Upper
respiratory
infections
54
866
Diarrhea
33
551
Scabies,
lice/ticks
8944
Chickenpox
1005
The
ongoing
armed
conflict
of
Israel-Palestine
mainly
strip
it
broke
on
7,
2023
is
a
severe
threat
to
region.
A
matter
greater
concern
public
health
devastated
city,
and
entire
area
humanitarian
disaster
zone.
deaths
worries
there
continue
rise
as
war
persists
for
this
long.
Further,
resulting
extreme
overcrowding
disrupted
health,
water
sanitation
services
intensify
perceptions.
Reportedly,
nearly
725
000
civilians
149
UNRWA
facilities,
about
131
134
94
non-UNRWA
schools
host
families,
122
shelter
hospitals,
churches
other
buildings.
There
only
one
shower
every
4500
people
toilet
220
an
average
today
[1].
Such
shabby
affairs
provide
conducive
environment
inevitable
spread
infectious
leading
potentially
endemic
situation.
situation
gradually
becoming
grimmer
rapidly
among
increasing
disease
transmission
risk
quite
critical
almost
1.5
million
displaced
across
Gaza,
especially
hugely
crowded
shelters
with
pitiable
access
hygiene,
safe
potable
[2].
Eventually,
bacterial
like
diarrhea
may
due
regular
consumption
unhealthy
contaminated
water.
This
region
has
reported
skin
rash,
upper
infections,
(over
half
whom
were
5-year
old
children
or
younger)
diarrhea,
scabies
lice/ticks,
chickenpox
cases
mid
2023[2].
These
numbers
confirmed
are
25
times
higher
compared
what
was
prior
that
still
ongoing.
Meningitis
hepatitis
also
suspected.
timely
preventive/therapeutic
interventions
shambles
routine
vaccination
programme
would
likely
further
complicate
scenario,
increase
accelerate
diseases.
Incomplete
surveillance
coverage,
limited
internet
could
constrain
ability
detect
potential
outbreaks
early
invoke
effective
countermeasure[2].
dwindling
fossil
fuel
availability
forced
shutting
down
desalinization
plants
solid
waste
collection,
create
rapid
widely
proliferating
disease-carrying
insects
rodent
pests.
strained
supply
cleaning
(hygiene
sanitation)
products
coupled
system
have
made
impossible
maintain
basic
prevention
control
measures
substantially
infection
arising
from
trauma,
surgery,
wound
care
childbirth.
Worsening
lack
personnel
protective
gears
healthcare
workers
lead
them
acquiring
transmitting
nosocomial
during
patient-care[2].
Disrupted
management
biomedical
wastes
at
hospitals
being
exposed
hazardous
materials
infections.
shortage
fuel,
medical
oxygen
essential
needs
besides
food
security
patients
caretakers,
facilities
(like
medicals,
clinics
diagnostic
labs)
seems
be
going
out
hand.
rely
heavily
volunteers
threadbare
nursing
staff
capacity[3].
As
result,
common
cause
mortality.
It
note
that,
82
COVID-19
400
2022.
In
recent
time,
many
SARS-CoV-2
variants
circulating
globally[4-6].
again
making
additional
challenge
will
even
more
susceptible
contracting
they
face
issues
security,
malnutrition
inclement
cold
weather.
currently
over
50
expecting
ladies
337
under
age
5
Gaza.
Therefore,
water,
supplies
aids
urgently
needed.
Nearly
2.2
classified
Phase
3
above
(crisis
worse)
between
8
December
7
February
2024
(Figure
1),
per
IPC's
(Integrated
Food
Security
Nutrition
Classification)
Acute
Insecurity
Classification[7].
hygiene
sanitation,
service
infrastructure
all
damaged
destroyed
owing
long
war,
thereby
limiting
capacity
address
outbreaks.
UNICEF
projects
most
life-threatening
form
known
"child
wasting"
shall
affect
10
(a
30%
pre-war
situation)
next
few
weeks
critically
vulnerable
335
5[8].Figure
1.:
Classified
(8
2023–7
2024).[
]
Malnutrition
person's
imbalanced
(deficient
excess)
nutrient-intake.
Under-nutrition,
inadequate
vitamins
minerals
intake
overweight/obesity
conditions
result
diet-related
noncommunicable
life-style
cardiac
(including
stroke),
diabetes
specific
cancers.
An
estimated
37
years
overweight
obese
suffered
stunting
2022[9].
Globally,
under-nutrition
reportedly
primary
50%
less,
mostly
occurring
low-
middle-income
countries.
Worldwide,
nation
malnutrition.
bigger
global
forms
malnutrition,
women,
infants,
adolescents
particularly
risk.
socio-economically
backward
community
more-likely
affected
population.
latest
IPC
report,
crisis
worse
levels
acute
insecurity
(the
exact
figure
standing
million)[7].
starving
sick
convalescing
individual
various
including
ones.
While
already
suffers
food,
necessary
medication
adequate
insufficiency,
relies
thrive,
famine
turn
terrible
catastrophe.
Limited
assistance
been
managed
delivered
by
UN,
international
agencies
non-governmental
organizations
NGOs)
so
far.
However,
falls
far
too
short
need
prevent
lethal
hunger,
combo[8].
Also,
alone
not
meet
clean
severely
northern
too.
increases
pneumonia
measles
breast-feeding
mother,
settings
life-saving
shambles.
With
daily
situation,
faces
"food
catastrophe"
looming
large[7].
high
rising
hunger
crisis,
acutely
children,
pregnant,
breastfeeding
women
elderly.
Dedicated
human
wellbeing,
WHO
leads
champions
efforts
everywhere
share
all,
equitable
healthy
life.
its
partners,
strives
scale
up
flexible
systems
numerous
existing
(that
escaped
devastation
yet)
strip.
such
concerning
scenario
current
trends,
stronger
countermeasures
back-ups
suggested
sake
humanity.
Language: Английский
Emerging SARS-CoV-2 Variants in Uganda in the Era of COVID-19 Vaccination
Viruses,
Journal Year:
2024,
Volume and Issue:
16(12), P. 1860 - 1860
Published: Nov. 29, 2024
The
emergence
of
SARS-CoV-2
variants
has
heightened
concerns
about
vaccine
efficacy,
posing
challenges
in
controlling
the
spread
COVID-19.
As
part
COVID-19
Vaccine
Effectiveness
and
Variants
(COVVAR)
study
Uganda,
this
aimed
to
genotype
characterize
patients
with
COVID-19-like
symptoms
who
tested
positive
on
a
real-time
PCR.
Amplicon
deep
sequencing
was
performed
163
oropharyngeal/nasopharyngeal
swabs
collected
from
symptomatic
patients.
Genome
assembly,
lineage
classification
phylogenetic
analysis
using
Edge
Bioinformatics
pipeline
version
2.4.0,
Pangolin
4.3.1
iqtree
2.3.6
software
respectively.
Of
sequences
analyzed
between
April
2023
March
2024,
most
common
were
XBB.1
lineages
sublineages
(113,
69.3%),
followed
by
JN.1*
(12,
7.4%),
XBB.2*
(11,
6.7%)
FL*
6.7%),
EG*
(7,
4.3%),
others
(BQ.1.1,
FY.4.1,
FY.4.1.2,
GY.2.1,
HK.27.1)
(5,
3.1%)
CM*
(4,
2.5%).
XBB.1*
dominated
July
2023;
thereafter,
other
variants,
including
increasingly
detected.
There
no
statistically
significant
association
status
assignment
(Fisher’s
exact
test,
p-value
=
0.994).
Our
findings
showed
that
Omicron
variant,
specifically
lineage,
dominant
circulating
virus.
However,
JN.1
variant
exhibits
spike
protein
mutation
profile
could
impact
transmission
Uganda.
Language: Английский
Role of nutraceuticals in viral infections as immunomodulators: A comprehensive review
Sunanda Biswas,
No information about this author
Souti Biswas,
No information about this author
G. Padmapriya
No information about this author
et al.
eFood,
Journal Year:
2024,
Volume and Issue:
5(5)
Published: Aug. 26, 2024
Abstract
Nutraceuticals
are
dietary
supplements
produced
from
food
sources
that
intended
to
improve
health
through
immune
system
modulation
or
by
helping
prevent
and
treat
a
variety
of
ailments.
Their
anti‐inflammatory,
immunomodulatory,
antioxidant
qualities
well
recognized.
In
certain
instances,
they
even
show
direct
microbiological
efficacy
against
viral
infections.
Because
their
special
capacity,
may
be
able
help
slow
the
spread
effects
very
infectious
illnesses,
such
as
pandemics
like
COVID‐19.
work
infections
because
number
intricate
processes.
Reducing
harm
do
is
one
main
effects.
have
power
stimulate
activate
system,
improving
body's
capacity
identify
eliminate
Additionally,
essential
in
reducing
oxidative
damage,
which
can
result
serious
consequences
frequently
intensified
during
also
strengthen
immunity
promoting
regulatory
T
cell
differentiation
proliferation,
crucial
for
preserving
homeostasis
limiting
hyperinflammatory
reactions.
They
control
production
proinflammatory
cytokines,
helps
avoid
cytokine
storms
seriously
tissue.
This
regulation
lowers
danger
hyperinflammation
enhances
overall
results
supporting
balanced
response.
Through
biochemical
mechanisms,
nutraceuticals
defenses
promote
more
effective
efficient
response
regulating
activities,
stress
reduction,
pathway
activation.
Furthermore,
interacting
with
different
cellular
signaling
pathways,
affect
synthesis
function
important
components.
study
clarifies
molecular
processes
behind
immunomodulatory
nutraceuticals,
highlighting
role
both
treating
preventing
Language: Английский